Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedMar 8, 2017Duopa (carbidopa and levodopa enteral suspension)Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within...AbbVie Inc. · D-0495-2017Class ITerminatedMar 8, 2017Domperidone capsules 10 mgMarketed without an approved NDA/ANDA for which safety and efficacy has not been established.Jeffreys Drug Store · D-0494-2017Class IITerminatedMar 8, 2017glipiZIDE Extended-Release TabletsPresence of Foreign Tablets/Capsules; bottles of Glipizide 5 mg tablets may contain Glipizide 10 mg tabletsMylan Pharmaceuticals Inc. · D-0491-2017Class IITerminatedMar 8, 2017CycloSPORINE CapsulesFailed Impurities/Degradations Specifications; out of specification results for Maximum Unknown Impurities and Total ImpuritiesAmerisource Health Services · D-0490-2017Class IIITerminatedMar 1, 2017Q Care Continue Care Kit for the non-ventilated patientLabeling: Incorrect or Missing Lot and/or Exp Date: The expiration date of the Q Care Continue Care kit is printed with an expiration date of November 13, 2017; rather...Sage Products Inc · D-0489-2017Class IITerminatedMar 1, 2017Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsulesSuperpotent Drug and Subpotent Drug; potency failures obtainedMoore's Compounding Pharmacy · D-0488-2017Class IITerminatedMar 1, 2017MakeSense PHARMA ANTIFUNGAL CREAM Clotrimazole 1%CGMP DeviationsCherry Hill Sales Co. · D-0487-2017Class IITerminatedMar 1, 2017MakeSense PHARMA ANTIFUNGAL CREAM 1 oz. Miconazole Nitrate 2%CGMP DeviationsCherry Hill Sales Co. · D-0486-2017Class IITerminatedMar 1, 2017MakeSense PHARMA Medicated ANTI-ITCH CREAM WITH SOOTHING ALOE VERA AND VITAMIN ECGMP DeviationsCherry Hill Sales Co. · D-0485-2017Class IITerminatedMar 1, 2017MakeSense PHARMA FIRST AID CREAM Lidocaine HCL 0.5%CGMP DeviationsCherry Hill Sales Co. · D-0484-2017Class IITerminatedMar 1, 2017MakeSense PHARMACGMP DeviationsCherry Hill Sales Co. · D-0483-2017Class IITerminatedMar 1, 2017Glipizide 2.5 mg ER TabletsFailed Dissolution SpecificationsRemedyRepack Inc. · D-0482-2017Class IITerminatedMar 1, 2017Transderm ScopLabeling: Incorrect Instructions:outer carton contains the incorrect instructions for Step 2 stating "Do cut the patch" rather than the correct instructions of "Do not...Sandoz Inc · D-0481-2017Class IITerminatedMar 1, 2017METRONIDazole InjectionLack of Sterility Assurance: customer report of leaking bagHospira Inc., A Pfizer Company · D-0480-2017Class IITerminatedMar 1, 2017CycloSPORINE CapsulesFailed Impurities/Degradations Specifications; out of specification results for Maximum Unknown Impurities and Total Impurities.Apotex Inc. · D-0475-2017Class IITerminatedFeb 22, 2017Mimvey LoFailed Impurities/Degradation Specifications: out of specification test results for the norethindrone impurity.Teva Pharmaceuticals USA · D-0479-2017Class IITerminatedFeb 22, 2017Lisinopril tabletsFailed tablet/capsule specification: missing break line on the 5mg tablet.Accord Healthcare, Inc. · D-0478-2017Class IIITerminatedFeb 22, 2017TaclonexLabeling: Incorrect or missing package insert: the affected product was packaged with an out-of-date package insert (PI) dated February 2014.Leo Pharma Inc · D-0477-2017Class IITerminatedFeb 22, 2017Glipizide extended-release tabletsFailed Dissolution Specifications. Above out of specification for dissolution rate observed at the 10 hour testing point.Actavis Inc · D-0476-2017Class IITerminatedFeb 22, 2017Venlafaxine Hydrochloride extended release capsulesFailed Tablet/Capsule Specifications: Some bottles contain punctured, and/or clumped/melted capsules.Aurobindo Pharma USA Inc · D-0474-2017Class ITerminatedFeb 22, 2017SLIMFIT X capsulesMarketed without an approved NDA/ANDA: Product contains undeclared sibutramine and desmethylsibutramine.Jersey Shore Supplements, LLC · D-0473-2017Class ITerminatedFeb 22, 2017MegaJex Herbal SupplementMarketed without an Approved NDA/ANDA; product contains sildenafil and tadalafil which are active pharmaceutical ingredients in FDA approved drugs used to treat erectile...MS Bionic · D-0472-2017Class IIITerminatedFeb 15, 2017Aripiprazole TabletsSuperpotent Drug: Product may not meet specifications throughout shelf life.Apotex Inc. · D-0471-2017Class IIITerminatedFeb 15, 2017Pantoprazole Sodium for InjectionDiscoloration: Some vials were found to contain powder with a yellowish-brownish appearance.Aurobindo Pharma USA Inc · D-0470-2017Class IITerminatedFeb 15, 2017Potassium Chloride Oral SolutionDefective Container: Leakage of unit dose cups that may occur at the seal.VistaPharm, Inc. · D-0469-2017Class IIITerminatedFeb 15, 2017Olanzapine tabletsFailed impurities/degradation specifications: due to out-of-specification result for the Related Substance Compound C (Impurity 6 - N-Oxide at the 18 month stability...Dr. Reddy's Laboratories, Inc. · D-0468-2017Class IITerminatedFeb 8, 2017Methadone Hydrochloride Oral ConcentrateCGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.VistaPharm, Inc. · D-0467-2017Class IITerminatedFeb 8, 2017Methadone Hydrochloride Oral ConcentrateCGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.VistaPharm, Inc. · D-0466-2017Class IITerminatedFeb 8, 2017Methadone Hydrochloride Oral ConcentrateCGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.VistaPharm, Inc. · D-0465-2017Class IITerminatedFeb 8, 2017Oxycodone Hydrochloride Oral SolutionCGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.VistaPharm, Inc. · D-0464-2017Class IITerminatedFeb 8, 2017Lactulose SolutionCGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.VistaPharm, Inc. · D-0463-2017Class IITerminatedFeb 8, 2017Lactulose SolutionCGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.VistaPharm, Inc. · D-0462-2017Class IITerminatedFeb 8, 2017Nystatin Oral SuspensionCGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.VistaPharm, Inc. · D-0461-2017Class IITerminatedFeb 8, 2017Phenytoin Oral SuspensionCGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.VistaPharm, Inc. · D-0460-2017Class IITerminatedFeb 8, 2017Metoclopramide Oral SolutionCGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.VistaPharm, Inc. · D-0459-2017Class IITerminatedFeb 8, 2017Hydrocodone Bitartrate and Acetaminophen Oral SolutionCGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.VistaPharm, Inc. · D-0458-2017Class IITerminatedFeb 8, 2017Nystatin Oral SuspensionCGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.VistaPharm, Inc. · D-0457-2017Class IITerminatedFeb 8, 2017MIDAZOLAM INJECTIONFailed Impurities/Degradation SpecificationsFresenius Kabi USA, LLC · D-0456-2017Class IITerminatedFeb 8, 2017Sun Pharma Carbidopa and Levodopa Tablets USP 25 mg/250 mg a)Failed Dissolution SpecificationsSun Pharmaceutical Industries, Inc. · D-0455-2017Class IIITerminatedFeb 8, 2017Endure 400 Scrub-StatSubpotent DrugEcolab, Inc. · D-0454-2017